Atai Life Sciences Return on Tangible Equity 2020-2025 | ATAI
Current and historical return on tangible equity values for Atai Life Sciences (ATAI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Atai Life Sciences Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2025-06-30 |
$-0.12B |
$0.14B |
-86.86% |
| 2025-03-31 |
$-0.15B |
$0.15B |
-102.60% |
| 2024-12-31 |
$-0.15B |
$0.11B |
-91.55% |
| 2024-09-30 |
$-0.13B |
$0.15B |
-65.56% |
| 2024-06-30 |
$-0.06B |
$0.17B |
-25.66% |
| 2024-03-31 |
$-0.03B |
$0.22B |
-14.30% |
| 2023-12-31 |
$-0.04B |
$0.24B |
-16.51% |
| 2023-09-30 |
$-0.07B |
$0.27B |
-27.02% |
| 2023-06-30 |
$-0.15B |
$0.22B |
-56.92% |
| 2023-03-31 |
$-0.15B |
$0.24B |
-53.07% |
| 2022-12-31 |
$-0.15B |
$0.27B |
-49.51% |
| 2022-09-30 |
$-0.20B |
$0.30B |
-58.11% |
| 2022-06-30 |
$-0.19B |
$0.32B |
-50.95% |
| 2022-03-31 |
$-0.21B |
$0.35B |
-48.58% |
| 2021-12-31 |
$-0.17B |
$0.39B |
-45.94% |
| 2021-09-30 |
$-0.17B |
$0.46B |
-56.75% |
| 2021-06-30 |
$-0.22B |
$0.49B |
-124.00% |
| 2021-03-31 |
$-0.19B |
$0.12B |
-344.19% |
| 2020-12-31 |
$-0.17B |
$0.10B |
-715.79% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.997B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
